<?xml version="1.0" encoding="UTF-8"?>
<ref id="fsn32021-bib-0029">
 <mixed-citation publication-type="journal" id="fsn32021-cit-0029">
  <string-name>
   <surname>Moine</surname>, 
   <given-names>E.</given-names>
  </string-name>, 
  <string-name>
   <surname>Denevault‐Sabourin</surname>, 
   <given-names>C.</given-names>
  </string-name>, 
  <string-name>
   <surname>Debierre‐Grockiego</surname>, 
   <given-names>F.</given-names>
  </string-name>, 
  <string-name>
   <surname>Silpa</surname>, 
   <given-names>L.</given-names>
  </string-name>, 
  <string-name>
   <surname>Gorgette</surname>, 
   <given-names>O.</given-names>
  </string-name>, 
  <string-name>
   <surname>Barale</surname>, 
   <given-names>J.‐C.</given-names>
  </string-name>, 
  <string-name>
   <surname>Jacquiet</surname>, 
   <given-names>P.</given-names>
  </string-name>, 
  <string-name>
   <surname>Brossier</surname>, 
   <given-names>F.</given-names>
  </string-name>, 
  <string-name>
   <surname>Gueiffier</surname>, 
   <given-names>A.</given-names>
  </string-name>, 
  <string-name>
   <surname>Dimier‐Poisson</surname>, 
   <given-names>I.</given-names>
  </string-name>, &amp; 
  <string-name>
   <surname>Enguehard‐Gueiffier</surname>, 
   <given-names>C.</given-names>
  </string-name> (
  <year>2015</year>). 
  <article-title>A small‐molecule cell‐based screen led to the identification of biphenylimidazoazines with highly potent and broad‐spectrum anti‐apicomplexan activity</article-title>. 
  <source xml:lang="en">European Journal of Medicinal Chemistry</source>, 
  <volume>89</volume>, 
  <fpage>386</fpage>–
  <lpage>400</lpage>. 
  <pub-id pub-id-type="doi">10.1016/j.ejmech.2014.10.057</pub-id>
  <pub-id pub-id-type="pmid">25462254</pub-id>
 </mixed-citation>
</ref>
